Sunzen Biotech Bhd (0148) — Capital Reinvestment Ratio
Sunzen Biotech Bhd (0148) has a Capital Reinvestment Ratio of 0.03x as of September 2023, meaning it reinvests 0% of its operating cash flow (RM3.58 Million) in capital expenditures (RM95.00K). See Sunzen Biotech Bhd balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sunzen Biotech Bhd Capital Reinvestment Ratio (2016–2023)
This chart tracks Sunzen Biotech Bhd's Capital Reinvestment Ratio across 4 annual periods. Check 0148 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Sunzen Biotech Bhd (2016–2023)
Year-by-year Capital Reinvestment Ratio for Sunzen Biotech Bhd from 2016 to 2023. For live market cap and broader valuation context, see market value of Sunzen Biotech Bhd.
| Year | Reinvestment Ratio | Operating CF (MYR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 1.23x | RM819.39K | RM1.01 Million | ▲ +667.0% |
| 2020 | 0.16x | RM7.20 Million | RM1.16 Million | ▼ -81.1% |
| 2017 | 0.85x | RM4.02 Million | RM3.42 Million | ▼ -96.7% |
| 2016 | 25.91x | RM256.13K | RM6.64 Million | — |